VIRIDIAN THERAPEUTICS INC

Ticker: VRDN CUSIP: 92790C104 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 43,985 Value ($000) $1,369 Avg Close $27.43 Range $20.69 - $34.04
Q3 2025
Shares 43,629 Value ($000) $942 Avg Close $18.04 Range $13.84 - $21.72
Q2 2025
Shares 43,629 Value ($000) $610 Avg Close $13.57 Range $9.90 - $16.29
Q1 2025
Shares 43,629 Value ($000) $588 Avg Close $17.03 Range $13.23 - $21.58
Q4 2024
Shares 44,295 Value ($000) $849 Avg Close $21.74 Range $17.06 - $27.20
Q3 2024
Shares 36,381 Value ($000) $828 Avg Close $16.35 Range $11.85 - $23.80
Q2 2024
Shares 36,381 Value ($000) $473 Avg Close $13.84 Range $11.40 - $17.69
Q1 2024
Shares 25,570 Value ($000) $448 Avg Close $19.39 Range $16.16 - $24.18
Q4 2023
Shares 22,271 Value ($000) $485 Avg Close $15.79 Range $10.93 - $23.53
Q3 2023
Shares 22,271 Value ($000) $342 Avg Close $19.08 Range $14.64 - $25.05
Q2 2023
Shares 22,271 Value ($000) $530 Avg Close $25.65 Range $21.96 - $30.30
Q1 2023
Shares 19,843 Value ($000) $505 Avg Close $32.06 Range $24.76 - $39.00
Q4 2022
Shares 19,843 Value ($000) $580 Avg Close $23.04 Range $18.00 - $29.99
Q3 2022
Shares 13,714 Value ($000) $281 Avg Close $17.98 Range $10.47 - $26.22
Q2 2022
Shares 13,714 Value ($000) $159 Avg Close $13.44 Range $9.47 - $20.18